Search Results
-drug interactions between psychiatric medications and MDMA or psilocybin: A systematic review . Psychopharmacology , 239 , 1945 – 1976 . https://doi.org/10.1007/s00213-022-06083-y . 10.1007/s00213-022-06083-y
-site crossover study to assess psychological effects of MDMA when administered to healthy volunteers . Retrieved 28 June 2020 from https://mapscontent.s3-us-west-1.amazonaws.com/pdfs/MT1+Santized+for+Website+Protocol+A5V2+Clean+08APR2020.pdf . Muthukumaraswamy
Introduction: pharmacovigilance beyond the individual level? In December 2023 the Multidisciplinary Association for Psychedelic Studies submitted a new drug application to the Food & Drug Administration for the use of MDMA in the treatment of post
-B [2,5-dimethoxy-4-bromophenethylamine] etc.), 5-MeO-DMT (5-methoxy- N,N -dimethyltryptamine), Ayahuasca (or analogues), smoked DMT ( N,N -Dimethyltryptamine), LSD (Lysergic acid diethylamide), MDMA (3,4-Methylenedioxy-methamphetamine), Mescaline
, psilocybin, MDMA, and ketamine . The Journal of Neuroscience , 41 ( 5 ), 891 – 900 . https://doi.org/10.1523/jneurosci.1659-20.2020 . 10.1523/JNEUROSCI.1659
-being or mental health. Accordingly, the following types of research were excluded: reviews or other non-empirical work, purely qualitative studies, studies on other psychoactive substances such as ketamine, cannabis or MDMA, studies on microdosing, studies
to rate how often their use of each of 12 drug categories (alcohol, tobacco, cannabis, MDMA, amphetamines, cocaine, opiates, classic psychedelics, inhalants, sedatives/hypnotics, dissociatives, atypical psychedelics) is motivated by entheogenic
Psychedelics and critical theory
A response to Hauskeller's individualization and alienation in psychedelic psychotherapy
not dismiss concerns raised around the cultural appropriation of Indigenous knowledges, it is important to recognise that the most medically-applied psychedelics to date are MDMA, LSD, psylocibin and ketamine—three out of four of which are in no way
. , & Meester , M. ( 2012 ). Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner . Journal of Psychoactive Drugs
%) Ayahuasca 4 (2%) 5-HT-2A research chemicals 3 (1%) Drug History LSD 174 (80%) Psilocybin 154 (71%) MDMA 38 (17%) DMT 29 (13%) Mescaline 28 (13%) Ayahuasca 5 (2%) 5-HT-2A research chemicals 12 (6%) Note . N represents the sum total number of participants who
